Healthcare Services

Increasing Adoption Of Rising Premature Births Drive Market Growth By Increasing Demand For Treatments That Improve Neonatal Respiratory Outcomes Is Influencing The Neonatal Respiratory Distress Syndrome Treatment Market

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Neonatal Respiratory Distress Syndrome Treatment Market During 2026–2030?

The neonatal respiratory distress syndrome treatment market has experienced robust expansion over the past few years. This market is projected to grow from $1.03 billion in 2025 to $1.11 billion in 2026, showing a compound annual growth rate (CAGR) of 8.0%. The historical growth can be linked to elevated premature birth rates, the dependence on conventional oxygen therapy, restricted access to neonatal intensive care units, the initial acceptance of natural surfactants, and an increase in infant respiratory morbidity.

The market size for neonatal respiratory distress syndrome treatment is projected to show robust growth over the next few years. By 2030, this market is anticipated to reach $1.5 billion, demonstrating a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this expansion during the forecast period include the advancement of synthetic surfactants, the widespread adoption of non-invasive ventilation technologies, increased investment in neonatal care equipment, heightened global awareness of neonatal complications, and the modernization of hospital respiratory support systems. Key trends anticipated in the forecast period encompass a greater uptake of surfactant replacement therapies, a rise in the application of CPAP and non-invasive ventilation, improvements in neonatal intensive care infrastructure, an increased emphasis on managing premature births, and the ongoing development of synthetic and bioengineered surfactants.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Primary Factors Are Fueling The Expansion Of The Neonatal Respiratory Distress Syndrome Treatment Market?

An increasing occurrence of premature births is anticipated to fuel the expansion of the neonatal respiratory distress syndrome treatment market. Premature births are defined as the birth of a baby prior to reaching 37 weeks of gestation, leading to immature organ systems that necessitate specialized medical intervention. A significant reason behind the growing rate of premature births is the higher incidence of maternal health complications, which can hinder typical fetal development and induce early labor due to the physiological stress they impose on both mother and fetus. Treatment for neonatal respiratory distress syndrome enhances survival rates and stabilizes premature infants, whose underdeveloped lungs make them highly susceptible to respiratory failure. For example, data from September 2024 by Statistique Canada, a Canadian governmental body, revealed that the percentage of births before 37 weeks of gestation saw a minor increase from 8.2% in 2022 to 8.3% in 2023, signifying a slight rise in preterm births. Consequently, the escalating rate of premature births is a primary driver for the expansion of the neonatal respiratory distress syndrome treatment market.

How Is The Neonatal Respiratory Distress Syndrome Treatment Market Distributed Across Key Segments?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

Which Trends Are Supporting The Evolution Of The Neonatal Respiratory Distress Syndrome Treatment Market?

Leading companies in the neonatal phototherapy market are concentrating on creating novel solutions, such as advanced open warmers, to enhance postnatal care for infants. An advanced open warmer (AOW) is defined as a medical apparatus frequently employed in neonatal and pediatric environments, designed to sustain a consistent body temperature for neonates and infants, particularly those born prematurely or with low birth weight. For instance, in October 2024, Draeger India Pvt. Ltd, an Indian enterprise specializing in medical and safety technology, introduced the BabyRoo TN300. This product was developed to provide versatility in both labor and delivery rooms and neonatal intensive care units. This cutting-edge device seeks to provide superior care for newborns, especially those requiring intensive medical attention post-delivery. The BabyRoo TN300 incorporates several features, including dual heat sources for steady temperature, skin temperature regulation for tailored warming, a prewarm capability for swift preparation, built-in thermomonitoring to identify thermal stress, respiratory support with an AutoBreath module to protect the lungs, and a family-centric care approach encouraging parents’ participation in infant nurturing.

Who Are The Leading Firms Participating In The Neonatal Respiratory Distress Syndrome Treatment Market?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Medtronic Plc, GE Healthcare, Koninklijke Philips NV, Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Windtree Therapeutics Inc., Discovery Laboratories Inc., ResMed Inc., Abbott Laboratories, Aerogen Pharma Corp., ONY Biotech, Yuhan Corporation, Atom Medical Corporation, Mindray Bio-Medical Electronics, Getinge AB, Nihon Kohden Corporation, Siare Engineering Spa

Access The Complete Neonatal Respiratory Distress Syndrome Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

Which Region Holds The Largest Share In The Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Neonatal Respiratory Distress Syndrome Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2026, By The Business Research Company

Neonatal Infant Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Light Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Image Guided Radiation Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795